Evidence map›Paper›PMID 24370892›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2014

Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer.

Helen Gosnell, Laura M Kasman, Thrimoorthy Potta, Lucas Vu, Elizabeth Garrett-Mayer, Kaushal Rege, Christina Voelkel-Johnson

Abstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Evaluation of drug carrier hepatotoxicity using primary cell culture models.Nanomedicine : nanotechnology, biology, and medicine · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Immune therapies in non-muscle invasive bladder cancer.Current treatment options in oncology · 2015
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Helen GosnellDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston 29425, USA.
Laura M KasmanDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston 29425, USA.
Thrimoorthy PottaChemical Engineering, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe 85287-6106 USA.
Lucas VuChemical Engineering, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe 85287-6106 USA.
Elizabeth Garrett-MayerDepartment of Public Health Sciences, Medical University of South Carolina, Charleston 29425, USA.
Kaushal RegeChemical Engineering, School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe 85287-6106 USA.
Christina Voelkel-JohnsonDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston 29425, USA. Electronic address: johnsocv@musc.edu.
Medical University of South Carolina · USArizona State University · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROUCH, ROSALIE K · 2002 to 2002
$2.0M
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics MethodsR01GM093229 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI REGE, KAUSHAL · 2011 to 2015
$1.5M
Targeted Polymer-Adenovirus Hybrids for Ablation of Bladder Cancer DiseaseR21CA143505 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI REGE, KAUSHAL, VOELKEL-JOHNSON, CHRISTINA · 2010 to 2011
$353k
NCI NIH HHS P30 CA138313NCI NIH HHS R21 CA143505NCRR NIH HHS C06 RR015455NIGMS NIH HHS R01 GM093229NIGMS NIH HHS R01GM093229
6 · The paper itself

Abstract

Gene therapy has garnered significant attention as a therapeutic approach for bladder cancer but efficient delivery and gene expression remain major hurdles. The goal of this study was to determine if cationic polymers can enhance adenoviral gene expression in cells that are difficult to transduce in vitro and to subsequently investigate lead candidates for their capacity to increase adenoviral gene expression in an orthotopic in vivo model of bladder cancer. In vitro screening of linear polyamine-based and aminoglycoside-based polymer libraries identified several candidates that enhanced adenoviral reporter gene expression in vitro. The polyamine-based polymer NPGDE-1,4 Bis significantly enhanced adenoviral gene expression in the orthotopic model of bladder cancer but unfortunately further use of this polymer was limited by toxicity. In contrast, the aminoglycoside-based polymer paromomycin-BGDE, enhanced adenoviral gene expression within the bladder without adverse events. Our study demonstrates for the first time that cationic polymers can enhance adenoviral gene expression in an orthotopic model of bladder cancer, thereby providing the foundation for future studies to determine therapeutic benefits of polymer-adenovirus combination in bladder cancer gene therapy.

Indexed as

Gene Transfer TechniquesAdenoviridaeAminoglycosidesAnimalsCell Line, TumorGene ExpressionGreen Fluorescent ProteinsHumansLuciferasesMicePolymersUrinary Bladder NeoplasmsAminoglycosidesGreen Fluorescent ProteinsLuciferasesPolymersAdenovirusBladder cancerCationic polymerGene deliveryOrthotopic

Identifiers

PMID24370892
PMCPMC3952388
OpenAlexW2063605986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.